PURE Bioscience, Inc. (PURE) Reports Q3 Loss of $0.05, Revenues Fall Year-Over-Year
Tweet
Share
E-mailGet Alerts PURE Hot Sheet
Price: $0.08 +33.33%
Financial Fact:
Total operating costs and expenses: 1.97M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Total operating costs and expenses: 1.97M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
PURE Bioscience, Inc. (NASDAQ: PURE) reported Q3 EPS of ($0.05), versus ($0.05) reported last year. Revenue for the quarter came in at $128.4 thousand, versus $536.5 thousand reported last year.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
- Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
